Skip to content

Study of RP2 alone and in combination with PD1 Blockade in patients with solid tumours

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512866-32-00
Acronym
RP2-001-18
Enrollment
32
Registered
2024-05-08
Start date
2022-07-12
Completion date
Unknown
Last updated
2025-12-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Solid tumors

Interventions

None listed

Sponsors

Replimune Group Inc.
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026